『Pure Global: Thailand's AI MedTech Gambit - Fast-Track Pitfalls.』のカバーアート

Pure Global: Thailand's AI MedTech Gambit - Fast-Track Pitfalls.

Pure Global: Thailand's AI MedTech Gambit - Fast-Track Pitfalls.

無料で聴く

ポッドキャストの詳細を見る

今ならプレミアムプランが3カ月 月額99円

2026年5月12日まで。4か月目以降は月額1,500円で自動更新します。

概要

 Thailand's FDA has launched an accelerated approval pathway for AI-based medical software, aiming to cement its position as a digital health leader in ASEAN. This presents a massive opportunity for innovators to enter this key market faster than ever before. But this speed comes at a price. The new 'Green Lane' is paired with unprecedentedly strict post-market surveillance duties, creating a new and costly layer of complexity for manufacturers. This episode of ASEAN MedTech Insights breaks down both the opportunity and the hidden operational risks of this groundbreaking regulatory shift. Imagine you are a MedTech scale-up with a brilliant AI diagnostic tool. You're thrilled by Thailand's 90-day approval promise, but you suddenly discover you must submit real-world performance data every quarter and integrate directly into local hospital EMRs for adverse event reporting. How do you seize this market opportunity without getting buried in unforeseen compliance costs and operational risks? Key Takeaways: * What are the exact criteria for an AI SaMD to qualify for Thailand's new 'Green Lane'? * How do the new quarterly PMS data requirements create new operational burdens? * What technical infrastructure is needed to comply with the mandatory adverse event reporting system? * Is this new Thai model a sign of a larger regulatory trend across the ASEAN region? * What are the key strategic mistakes companies can make when rushing to use this fast-track pathway? * How can startups balance the cost of advanced post-market surveillance with the benefit of faster market entry? * Which other ASEAN countries are likely to adopt a similar regulatory framework for digital health? Pure Global offers end-to-end regulatory consulting solutions for Medical Technology (MedTech) and In-Vitro Diagnostic (IVD) companies, combining local expertise with advanced AI and data tools to streamline global market access. Contact Pure Global at info@pureglobal.com or visit us at https://pureglobal.com.
adbl_web_anon_alc_button_suppression_c
まだレビューはありません